The Multiple Kill Vehicle-L (MKV-L) missile defense program saw progress as its algorithms were tested, Lockheed Martin Corp. [LMT] announced. MKV-L is designed to counter multiple targets, such as an enemy missile that spews forth multiple warheads or confusing countermeasures such as decoys. With MKV, a single rocket booster carries a payload of several kill vehicles, perhaps eight or more, which then are guided to take out the incoming threats. In testing the algorithms, staffers used a software test bed…
Recommended
Trending
Congress Updates
Trump Wants Second Reconciliation Bill On His Desk By June 1
President Donald Trump on Wednesday called on Congress to pass and send a second reconciliation bill to his desk by June 1. The deadline follows congressional Republicans’ backing a pursuit […]
Upgrading Current GPS Ground System “Now a Viable Option,” As GPS OCX Problems Continue, Space Official Says
Upgrades to the GPS ground system–the Architecture Evolution Plan (AEP)–is an option under consideration by the Defense Department’s space acquisition chief, as problems continue in fielding the GPS Next Generation […]
Graham Says GOP To Move Ahead On Second Reconciliation Bill, With Defense Funds As Priority
Senate Budget Committee Chair Lindsey Graham (R-S.C.) said Wednesday, with the White House’s backing, his panel will move “expeditiously” on crafting a second reconciliation bill, citing priorities for defense and […]
Hegseth Acknowledges Potential $200 Billion Iran Supplemental Request, Final Figure ‘Could Move’
Defense Secretary Pete Hegseth on Thursday acknowledged the Pentagon could potentially ask Congress for $200 billion in supplemental funding to support the ongoing operation against Iran and replenish munitions used […]
Job Feed
-
Sr. Business Information Security Officer
Spanish and Portuguese - Bank of America - Chicago, IL -
Senior/ Principal Aerospace Engineer, AFSIM
Onsite - Sandia National Laboratories - Albuquerque, NM -
Cleared Principal Systems Engineer
Critical Infrastructure Systems, Onsite - Sandia National Laboratories - Albuquerque, NM -
Chief, Gastrointestinal (GI) Medical Oncology (3-309-1321)
University of Maryland, Baltimore - Baltimore, MD